pre-IPO PHARMA
COMPANIES VC JOBS NEWS CONTACT

TAG: IPO

Sep 19, 2023

RayzeBio, Inc. Announces Closing of Upsized $358 Million Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Sep 14, 2023

RayzeBio, Inc. Announces Pricing of Upsized $311 Million Initial Public Offering

Jul 21, 2023

Turnstone Biologics Corp. Announces Pricing of Upsized Initial Public Offering

May 9, 2023

ACELYRIN, INC. Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

May 4, 2023

ACELYRIN, INC. Announces Pricing of Upsized Initial Public Offering

May 1, 2023

ACELYRIN, INC. Announces Launch of IPO Roadshow

Apr 26, 2023

Scottish Biotech ILC Therapeutics Sets Sights on Series A and IPO After Recent Investment Round

Jan 3, 2023

Coya Therapeutics, Inc. Announces Closing of $15.25 Million Initial Public Offering

Dec 19, 2022

Lipella Pharmaceuticals Announces Pricing of Initial Public Offering of Common Stock

Aug 1, 2022

MAIA Biotechnology Announces Closing of Initial Public Offering

Jul 27, 2022

MAIA Biotechnology Announces Pricing of Initial Public Offering

Feb 23, 2022

Blue Water Vaccines Announces Closing of Initial Public Offering

Feb 17, 2022

Blue Water Vaccines Announces Pricing of approximate $20M Initial Public Offering

Feb 4, 2022

Arcellx Announces Pricing of Initial Public Offering

Jan 6, 2022

CinCor Pharma Announces Pricing of Initial Public Offering

Jan 6, 2022

Amylyx Pharmaceuticals Announces Pricing of Upsized Initial Public Offering of Common Stock

Jan 3, 2022

Amylyx Pharmaceuticals Announces Launch of Initial Public Offering

Jan 3, 2022

CinCor Pharma Launches Roadshow for Proposed Initial Public Offering of Common Stock

Dec 14, 2021

Genenta Announces Pricing of Upsized Initial Public Offering

Nov 10, 2021

Genenta Announces Filing of Registration Statement for Proposed Initial Public Offering

Nov 9, 2021

Novo Holdings and Lundbeckfonden Portfolio Company IO Biotech Closes Initial Public Offering on the Nasdaq Global Market

Nov 3, 2021

MaaT Pharma announces successful Initial Public Offering on the regulated market of Euronext Paris

Oct 28, 2021

Aura Biosciences Announces Pricing of Initial Public Offering

Oct 28, 2021

Entrada Therapeutics Announces Pricing of Upsized Initial Public Offering

Oct 21, 2021

Xilio Therapeutics Announces Pricing of Initial Public Offering

Oct 20, 2021

LianBio Announces Launch of Initial Public Offering

Oct 19, 2021

MiNK Therapeutics Announces Closing of Initial Public Offering

Oct 15, 2021

MaaT Pharma Launches Its Initial Public Offering on the Regulated Market of Euronext in Paris

Oct 14, 2021

MiNK Therapeutics, Inc. Announces Pricing of Initial Public Offering

Oct 8, 2021

Cognition Therapeutics Announces Pricing of Upsized Initial Public Offering

Oct 5, 2021

Exscientia Announces Closing of $510.4 Million Aggregate Financing, Consisting of $350.4 Million Upsized Initial Public Offering With Full Exercise of Underwriters’ Option to Purchase Additional ADSs and $160.0 Million Concurrent Private Placement

Oct 4, 2021

Cognition Therapeutics Announces Launch of its Initial Public Offering

Oct 4, 2021

MaaT Pharma Announces the Approval of Its Registration Document by the French Financial Markets Authority (Autorité des marchés financiers) as Part of Its Proposed IPO on the Euronext Paris Regulated Market

Sep 30, 2021

Exscientia Announces Pricing of $304.7 Million Upsized Initial Public Offering and $160.0 Million Concurrent Private Placements

Sep 8, 2021

Tenaya Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Updates

Aug 13, 2021

Rani Therapeutics Announces Closing of its Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Aug 5, 2021

Adagio Therapeutics Announces Pricing of Initial Public Offering

Aug 3, 2021

Immuneering Announces Closing of its Upsized Initial Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares

Aug 3, 2021

Tenaya Therapeutics Announces Closing of Upsized Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

Jul 30, 2021

Rani Therapeutics Announces Pricing of Initial Public Offering

Jul 30, 2021

IN8bio Announces Pricing of Initial Public Offering

Jul 29, 2021

Immuneering Announces Pricing of Upsized Initial Public Offering

Jul 29, 2021

Tenaya Therapeutics Announces Pricing of Upsized Initial Public Offering

Jul 28, 2021

Rallybio Corporation Announces Pricing of Initial Public Offering

Jul 28, 2021

MiNK Therapeutics Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering

Jul 27, 2021

Caribou Biosciences Announces Closing of Upsized Initial Public Offering

Jul 23, 2021

ImmixBio Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering

Jul 22, 2021

Caribou Biosciences Announces Pricing of Upsized Initial Public Offering

Jul 22, 2021

IN8bio Launches Proposed Initial Public Offering

Jul 20, 2021

Imago BioSciences, Inc. Announces Closing of $134.4 Million Initial Public Offering

Jul 15, 2021

Imago BioSciences, Inc. Announces Pricing of Upsized Initial Public Offering of Common Stock

Jul 12, 2021

Imago BioSciences, Inc. Announces Proposed Initial Public Offering of Common Stock

Jul 8, 2021

TransCode Therapeutics, Inc. Announces Pricing of Initial Public Offering

Jul 2, 2021

Aerovate Therapeutics Announces Closing of Initial Public Offering with Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

Jun 30, 2021

Graphite Bio Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Jun 29, 2021

Aerovate Therapeutics Announces Pricing of Upsized Initial Public Offering

Jun 24, 2021

Elevation Oncology Announces Pricing of Initial Public Offering

Jun 24, 2021

Graphite Bio Announces Pricing of Upsized Initial Public Offering

Jun 17, 2021

Ambrx Announces Pricing of Initial Public Offering

Jun 17, 2021

Cyteir Therapeutics Announces Pricing of Initial Public Offering

Jun 16, 2021

Verve Therapeutics Announces Pricing of Initial Public Offering

Jun 16, 2021

Lyell Immunopharma Announces Pricing of Initial Public Offering

Jun 15, 2021

Janux Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Jun 11, 2021

Janux Therapeutics Announces Pricing of Initial Public Offering

Jun 1, 2021

Day One Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

May 26, 2021

Day One Announces Pricing of Upsized Initial Public Offering

May 20, 2021

Biomea Announces Closing of Initial Public Offering

May 15, 2021

Biomea Announces Pricing of Initial Public Offering

May 7, 2021

Gyroscope Therapeutics Postpones Initial Public Offering

May 3, 2021

Gyroscope Therapeutics Announces Launch of Initial Public Offering

Apr 26, 2021

Zymergen Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Apr 22, 2021

Rain Therapeutics Announces Pricing of Initial Public Offering

Apr 21, 2021

Zymergen Announces Pricing of Upsized Initial Public Offering

Apr 16, 2021

Gyroscope Therapeutics Files Registration Statement for Proposed Initial Public Offering in the United States

Apr 14, 2021

Zymergen Announces Launch of Initial Public Offering

Mar 25, 2021

Gain Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Overallotment Option to Purchase Additional Shares

Mar 23, 2021

Instil Bio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Mar 18, 2021

Gain Therapeutics Announces Pricing of Initial Public Offering of Common Stock

Mar 18, 2021

Finch Therapeutics Announces Pricing of Upsized Initial Public Offering

Mar 18, 2021

Instil Bio Announces Pricing of Upsized Initial Public Offering

Mar 16, 2021

Prometheus Biosciences Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Mar 16, 2021

NeoImmuneTech Announces Closing of Initial Public Offering

Mar 11, 2021

Prometheus Biosciences Announces Upsized Pricing of Initial Public Offering

Mar 10, 2021

Gain Therapeutics Files Registration Statement with SEC for Proposed Initial Public Offering

Feb 17, 2021

NexImmune Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Feb 11, 2021

NexImmune Announces Pricing of Upsized Initial Public Offering

Feb 11, 2021

Adagene Inc. Announces Closing of Initial Public Offering and Exercise of Underwriters' Over-Allotment Option

Feb 10, 2021

PureTech Founded Entity Vor Biopharma Closes Over $200M Initial Public Offering

Feb 9, 2021

Adagene Inc. Announces Pricing of Initial Public Offering

Feb 9, 2021

Cambrian Biopharma announces $60M in financing to develop a pipeline of companies and therapeutics to treat diseases of aging, coupled with a unique operational strategy

Feb 8, 2021

Sana Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Feb 5, 2021

PureTech Founded Entity Vor Biopharma Announces Pricing of Initial Public Offering

Feb 4, 2021

Pharvaris Announces Pricing of Upsized Initial Public Offering

Feb 3, 2021

Sana Announces Upsized Pricing of Initial Public Offering

Feb 1, 2021

Terns Pharmaceuticals, Inc. Announces Proposed Initial Public Offering of Common Stock

Feb 1, 2021

Sensei Biotherapeutics Announces Launch of Initial Public Offering

Jan 8, 2021

Gracell Biotechnologies Announces Pricing of Initial Public Offering

Dec 30, 2020

NeoImmuneTech Receives Notice of Approval from the Korea Exchange for Initial Public Offering on the KOSDAQ

Dec 15, 2020

AbCellera Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

Dec 10, 2020

AbCellera Announces Pricing of Initial Public Offering

Dec 8, 2020

Sigilon Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Dec 8, 2020

Silverback Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Dec 7, 2020

Kinnate Biopharma Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

Dec 3, 2020

Sigilon Therapeutics Announces Pricing of Upsized Initial Public Offering

Dec 3, 2020

Silverback Therapeutics Announces Pricing of Initial Public Offering

Dec 2, 2020

Kinnate Biopharma Announces Pricing of Initial Public Offering

Nov 9, 2020

Inozyme Pharma Announces Closing of Initial Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares

Nov 9, 2020

Global Health Sciences Fund (Quark Venture LP and GF Securities) Announces Portfolio Company SQZ Biotechnologies’ IPO

Nov 3, 2020

Atea Pharmaceuticals Announces Closing of Initial Public Offering

Oct 29, 2020

Atea Pharmaceuticals Announces Pricing of Initial Public Offering

Oct 28, 2020

Galecto Announces Pricing of Initial Public Offering

Oct 20, 2020

Tarsus Pharmaceuticals, Inc. Announces Closing of Initial Public Offering and Full Exercise by the Underwriters of Option to Purchase Additional Shares

Oct 15, 2020

Tarsus Pharmaceuticals Inc. Announces Pricing of Initial Public Offering

Oct 15, 2020

Aligos Therapeutics Announces Pricing of Initial Public Offering

Sep 29, 2020

Taysha Gene Therapies Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Sep 29, 2020

Prelude Therapeutics Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Sep 29, 2020

PMV Pharma Announces Closing of $243.5 Million Initial Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares

Sep 24, 2020

Prelude Therapeutics Announces Pricing of Initial Public Offering

Sep 24, 2020

Taysha Gene Therapies Announces Pricing of Initial Public Offering

Sep 24, 2020

PMV Pharma Announces Pricing of Initial Public Offering

Sep 21, 2020

Dyne Therapeutics Announces Closing of Initial Public Offering

Sep 16, 2020

Dyne Therapeutics Announces Pricing of Initial Public Offering

Sep 15, 2020

Metacrine Announces Pricing of Initial Public Offering

Aug 21, 2020

Harmony Biosciences Announces Closing Of Its Upsized Initial Public Offering And Exercise In Full Of Underwriters' Option To Purchase Additional Shares

Aug 20, 2020

Kymera Therapeutics Announces Pricing of Upsized Initial Public Offering

Aug 18, 2020

Harmony Biosciences Announces Pricing Of Upsized Initial Public Offering

Aug 3, 2020

AlloVir Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Jul 30, 2020

AlloVir Announces Pricing of Upsized Initial Public Offering

Jul 23, 2020

Nurix Therapeutics Announces Pricing of $209 Million Initial Public Offering

Jul 23, 2020

iTeos Therapeutics Announces Pricing of Initial Public Offering

Jul 23, 2020

Inozyme Pharma Announces Pricing of Initial Public Offering

Jul 17, 2020

Oak Stone Limited Says Relay Therapeutics IPO Soars In Trading Debut

Jul 16, 2020

ALX Oncology Announces Pricing of Initial Public Offering

Jun 30, 2020

PolyPid Ltd. Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares English English

Jun 26, 2020

PolyPid Ltd. Announces Pricing of Initial Public Offering English English

Jun 23, 2020

Repare Therapeutics Announces Closing of Upsized Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

Jun 18, 2020

Repare Therapeutics Announces Pricing of Upsized Initial Public Offering

Jun 18, 2020

Forma Therapeutics Announces Pricing of Initial Public Offering

Jun 16, 2020

Generation Bio Announces Closing of Initial Public Offering

Jun 11, 2020

Generation Bio Announces Pricing of Initial Public Offering

Jun 5, 2020

Pliant Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Option to Purchase Additional Shares

Jun 2, 2020

Pliant Therapeutics Announces Pricing of Initial Public Offering

May 20, 2020

4BIO Capital portfolio company ADC Therapeutics SA closes an upsized IPO of over $267.6 million

May 14, 2020

ADC Therapeutics Announces Pricing of Upsized Initial Public Offering

May 5, 2020

Lyra Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares

Apr 30, 2020

Lyra Therapeutics Announces Pricing of Initial Public Offering

Feb 27, 2020

Passage Bio Announces Pricing of Initial Public Offering

Feb 23, 2020

PolyPid Announces Intention to Submit Confidential Draft Registration Statement for Proposed U.S. Initial Public Offering

Feb 23, 2020

PolyPid Announces Intention to Submit Confidential Draft Registration Statement for Proposed U.S. Initial Public Offering English English

Feb 12, 2020

Revolution Medicines Announces Pricing of Initial Public Offering

Feb 11, 2020

Beam Therapeutics Announces Pricing of Initial Public Offering

Feb 11, 2020

Beam Therapeutics Announces Closing of Initial Public Offering

Feb 3, 2020

Black Diamond Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

Dec 18, 2019

Monopar Therapeutics Inc. Announces Pricing of Initial Public Offering

Nov 13, 2019

89bio Announces Closing of Upsized Initial Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

Nov 11, 2019

89bio Announces Pricing of Upsized Initial Public Offering

Oct 13, 2019

89bio Files Preliminary Prospectus for IPO

Oct 8, 2019

Karolinska Development’s portfolio company Aprea Therapeutics Announces Closing of Initial Public Offering

Oct 7, 2019

Aprea Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Oct 7, 2019

Viela Bio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Oct 4, 2019

Oyster Point Pharma Announces Filing of Registration Statement for Proposed Initial Public Offering

Oct 2, 2019

Frequency Therapeutics Announces Pricing of Initial Public Offering

Oct 2, 2019

Viela Bio Announces Pricing of Initial Public Offering

Oct 2, 2019

Aprea Therapeutics Announces Pricing of Initial Public Offering

Sep 30, 2019

Fortis Minerals Files Registration Statement for Proposed Initial Public Offering

Sep 23, 2019

Karolinska Development’s portfolio company Aprea Therapeutics sets price range for potential initial public offering

Sep 23, 2019

ADC Therapeutics Announces Launch of Initial Public Offering

Sep 13, 2019

Imara Submits Confidential Draft Registration Statement for Proposed Initial Public Offering

Sep 6, 2019

ADC Therapeutics Files Registration Statement for Proposed Initial Public Offering

Sep 5, 2019

Precision IBD Announces Next Phase Of Growth: Appoints Mark C. McKenna As President And Chief Executive Officer, Completes Name Change To Prometheus Biosciences, Inc.

Jul 17, 2019

Mirum Pharmaceuticals Announces Pricing of Initial Public Offering

Jul 17, 2019

Fulcrum Therapeutics Announces Pricing of Initial Public Offering

Jul 2, 2019

Karuna Therapeutics Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Jun 27, 2019

Karuna Therapeutics Announces Pricing of Upsized Initial Public Offering

Jun 26, 2019

BridgeBio Pharma Announces Pricing of Its Initial Public Offering

Jun 24, 2019

Akero Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

Jun 21, 2019

Stoke Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Jun 19, 2019

Akero Therapeutics Announces Pricing of Initial Public Offering

Jun 19, 2019

Prevail Therapeutics Announces Pricing of Initial Public Offering

Jun 19, 2019

Atreca Announces Pricing of Initial Public Offering

Jun 18, 2019

Stoke Therapeutics Announces Pricing of Initial Public Offering

May 28, 2019

IDEAYA Biosciences Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

May 24, 2019

Atreca Files Preliminary Prospectus for IPO

May 24, 2019

Akero Therapeutics Files Preliminary Prospectus for IPO

May 24, 2019

BridgeBio Pharma Announces Filing of Registration Statement for Proposed Initial Public Offering

May 22, 2019

Bicycle Therapeutics Announces Pricing of Initial Public Offering

May 22, 2019

IDEAYA Announces Pricing of Initial Public Offering

May 8, 2019

Milestone Pharmaceuticals Announces Pricing of Upsized Initial Public Offering

May 8, 2019

Cortexyme, Inc. Announces Pricing of Initial Public Offering

May 7, 2019

Trevi Therapeutics Announces Pricing of Initial Public Offering

May 1, 2019

Codiak Biosciences Files Preliminary Prospectus for IPO

Apr 29, 2019

Bicycle Therapeutics Files Preliminary Prospectus for IPO

Apr 29, 2019

Peloton Therapeutics Files Preliminary Prospectus for IPO

Apr 29, 2019

IDEAYA Biosciences Files Preliminary Prospectus for IPO

Apr 26, 2019

Karuna Therapeutics Files Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering

Apr 17, 2019

HOOKIPA Pharma Announces Pricing of Initial Public Offering

Apr 16, 2019

Turning Point Therapeutics Announces Pricing of Initial Public Offering

Apr 3, 2019

NGM Bio Announces Pricing of Initial Public Offering

Mar 27, 2019

Precision BioSciences Announces Pricing of Initial Public Offering

Mar 25, 2019

NGM Bio Files Preliminary Prospectus for IPO

Mar 21, 2019

Turning Point Therapeutics Files Registration Statement for Proposed Initial Public Offering

Jun 27, 2018

Translate Bio Announces Pricing of Initial Public Offering

Jun 18, 2018

Translate Bio Launches Proposed Initial Public Offering

May 2, 2018

Alzheon Launches Roadshow for Initial Public Offering

Dec 5, 2017

Advicenne raises €27 million in successful IPO on Euronext Paris

Oct 20, 2016

Karolinska Development company Dilaforette to change name to Modus Therapeutics and announces intention to conduct an Initial Public Offering

Apr 8, 2015

SanBio Announces Pricing of Initial Public Offering on Tokyo Stock Exchange

Jul 30, 2014

Innocoll AG Announces Closing of Initial Public Offering

Jul 25, 2014

Innocoll AG Announces Pricing of Initial Public Offering

Apr 3, 2014

Corium International, Inc. Announces Pricing of Initial Public Offering

Mar 3, 2014

Corium International, Inc. Files Registration Statement for Proposed Initial Public Offering